Zurcher Kantonalbank (Zurich Cantonalbank) Precigen, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Precigen, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 10,940 shares of PGEN stock, worth $36,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,940
Previous 12,084
9.47%
Holding current value
$36,211
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PGEN
# of Institutions
164Shares Held
166MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$276 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$53.8 Million1.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$37.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$33.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$30 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $689M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...